OR WAIT 15 SECS
In a partnership with top health care experts, MJH Life Sciences™ COVID-19 Coalition will host its inaugural event, "Battling Dual Threats: Flu and COVID-19 Converge" on Tuesday, September 15, at 6 p.m. EDT.
To kick off its partnership with top health care experts, the newly launched MJH Life Sciences™ COVID-19 Coalition will host its inaugural webinar event exploring dual threats as flu season and the coronavirus disease 2019 (COVID-19) converge.
"Battling Dual Threats: Flu and COVID-19 Converge," a free, live, 1-hour webinar, will be broadcasted on Tuesday, September 15, at 6 p.m. EDT.
Through an alliance with renowned thought leaders, MJH Life Sciences™ COVID-19 Coalition will equip providers with the resources they need to enhance patient outcomes as they navigate through the coronavirus pandemic. The Coalition will comprise of a group of nationally recognized experts who will serve as an advisory panel.
"There is still much confusion among health care providers as they navigate patient care during the pandemic," said Mike Hennessy Jr., president and CEO of MJH Life Sciences™. "This is why we've assembled some of the brightest and most prominent thought leaders in health care to provide the latest and best guidance and direction."
The series builds off MJH's recent successes with 2 previous COVID-focused webinars, "COVID-19: A Race for a Vaccine" and "COVID-19: Debating the Road Back to School."
Initial members of the Coalition advisory panel are:
The upcoming inaguaral webinar event will focus on the convergence of COVID-19 and influenza this fall, as health care professionals brace for the impact of dual epidemics.
The webinar will cover:
Panelists will include moderator and Coalition member Angela Rasmussen, PhD; Juliet Morrison, PhD, assistant professor at the University of California Riverside; and Andreas Handel, PhD, associate professor in the Department of Epidemiology and Biostatistics at the University of Georgia.
To register for the webinar, click here.
The Coalition will continue to offer bi-weekly webinars with discussion, viewpoints, and audience Q&A, and an array of insight pieces on key COVID-related topics.